We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.57M
Cap. Flow %
-2.89%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$689K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$468K
4
ENIC icon
Enel Chile
ENIC
+$430K
5
EFT
Eaton Vance Floating-Rate Income Trust
EFT
+$429K

Top Sells

Rank Stock Value
1
GRA
W.R. Grace & Co.
GRA
+$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
+$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
+$693K
4
NOA
North American Construction
NOA
+$554K
5
MCI
Barings Corporate Investors
MCI
+$524K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
176
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$399K 0.18%
10,703
-976
-8% -$33.9K
OCSL icon
177
Oaktree Specialty Lending
OCSL
$1.04B
$398K 0.18%
18,781
-2,013
-10% -$42.5K
BRW
178
Saba Capital Income & Opportunities Fund
BRW
$336M
$392K 0.17%
43,098
+1,359
+3% +$12.5K
PTCT icon
179
PTC Therapeutics
PTCT
$6.29B
$388K 0.17%
10,416
-952
-8% -$39.1K
BBDC icon
180
Barings BDC
BBDC
$868M
$385K 0.17%
34,951
-32,777
-48% -$353K
INCY icon
181
Incyte
INCY
$23.7B
$381K 0.17%
5,536
-506
-8% -$38.5K
RIGL icon
182
Rigel Pharmaceuticals
RIGL
$692M
$380K 0.17%
10,466
-960
-8% -$37.8K
AGIO icon
183
Agios Pharmaceuticals
AGIO
$2.2B
$362K 0.16%
7,849
-724
-8% -$35K
YMAB
184
DELISTED
Y-mAbs Therapeutics
YMAB
$359K 0.16%
12,578
-1,150
-8% -$36.2K
CYTK icon
185
Cytokinetics
CYTK
$10.9B
$348K 0.15%
9,723
-514
-5% -$15.1K
OFS icon
186
OFS Capital
OFS
$46M
$343K 0.15%
+33,086
New +$331K
KNSA icon
187
Kiniksa Pharmaceuticals
KNSA
$4.89B
$342K 0.15%
30,009
-2,753
-8% -$35.9K
BCIC
188
BCP Investment Corp
BCIC
$88.1M
$342K 0.15%
+14,059
New +$338K
SUNS
189
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$326K 0.14%
21,102
-605
-3% -$9.46K
CCAP icon
190
Crescent Capital BDC
CCAP
$403M
$325K 0.14%
17,002
+3,754
+28% +$70.6K
NTLA icon
191
Intellia Therapeutics
NTLA
$1.49B
$325K 0.14%
2,419
-123
-5% -$18.6K
BIIB icon
192
Biogen
BIIB
$29.5B
$320K 0.14%
1,131
-98
-8% -$32.1K
FCRD
193
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$320K 0.14%
72,451
-1,503
-2% -$6.87K
PRTA icon
194
Prothena Corp
PRTA
$455M
$318K 0.14%
4,458
-236
-5% -$14.7K
ICPT
195
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$318K 0.14%
21,387
-1,966
-8% -$31.5K
MRCC
196
DELISTED
Monroe Capital Corp
MRCC
$316K 0.14%
30,457
-454
-1% -$4.9K
OXSQ icon
197
Oxford Square Capital
OXSQ
$148M
$316K 0.14%
78,022
+10,825
+16% +$49.2K
AVIR icon
198
Atea Pharmaceuticals
AVIR
$386M
$313K 0.14%
8,932
-463
-5% -$12.8K
GOSS icon
199
Gossamer Bio
GOSS
$97.5M
$303K 0.13%
24,110
-1,251
-5% -$11.5K
RCUS icon
200
Arcus Biosciences
RCUS
$3.5B
$302K 0.13%
8,664
-447
-5% -$13.9K
6 7
8
9 10

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Virtus ETF Advisers held 407 positions worth $227M, down 6.5% from $243M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.4%. Virtus ETF Advisers opened 8 new positions and exited 10, leaving the 407-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Real Estate and Energy.

  • Virtus ETF Advisers's largest Q3 2021 buy was XAI Floating Rate & Alternative Income Trust: 15,447 shares worth $663K.
  • Virtus ETF Advisers added most to Enel Chile in Q3 2021, an estimated $430K increase.
  • Virtus ETF Advisers's biggest Q3 2021 reduction was North American Construction, cutting an estimated $554K.
  • Virtus ETF Advisers fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.73M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $227M portfolio in Q3 2021.
  • Virtus ETF Advisers opened 8 new positions and closed 10 in Q3 2021.
  • Virtus ETF Advisers's portfolio value fell 6.5% quarter-over-quarter to $227M.

Based on Virtus ETF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.